Literature DB >> 8803382

Ketorolac continuous infusion: a case report and review of the literature.

R K Middleton1, J A Lyle, D L Berger.   

Abstract

We report a case of intractable pain due to metastatic carcinoma that was effectively managed with a continuous intravenous (IV) infusion of ketorolac. Unlike previous reports of short-term continuous IV ketorolac for postoperative analgesia, this case is unique because of the etiology of the pain and the duration of treatment. The published literature on continuous administration of ketorolac by the intravenous, intramuscular, and subcutaneous routes is also reviewed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8803382     DOI: 10.1016/0885-3924(96)00129-7

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  4 in total

Review 1.  Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management.

Authors:  J C Gillis; R N Brogden
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

2.  A double-blind randomized controlled trial of continuous intravenous Ketorolac vs placebo for adjuvant pain control after renal surgery.

Authors:  Gwen M Grimsby; Sarah P Conley; Terrence L Trentman; Erik P Castle; Paul E Andrews; Laurie A Mihalik; Joseph G Hentz; Mitchell R Humphreys
Journal:  Mayo Clin Proc       Date:  2012-10-08       Impact factor: 7.616

Review 3.  The dying patient.

Authors:  J D Cowan
Journal:  Curr Oncol Rep       Date:  2000-07       Impact factor: 5.075

Review 4.  Analgesia for patients with advanced disease: 2.

Authors:  E J Hall; N P Sykes
Journal:  Postgrad Med J       Date:  2004-04       Impact factor: 2.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.